文献速递腹部泌尿生殖MR

扩散加权MRI与对比增强MRI在鉴别实性肾脏肿块及肾细胞癌亚型中的作用

The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes.
PubMed 文献 · Abdom Radiol (NY) · 2020-09-15

本研究评估DW-MRI与CE-MRI鉴别良恶性实性肾脏肿块、肾细胞癌亚型、嗜酸细胞瘤及乏脂性血管平滑肌脂肪瘤的价值。共测量112个肾脏肿块(良性46个、恶性66个)的ADC值及CE-MRI信号强度、对比增强率和对比增强指数。良恶性肿块间ADC值与信号强度无显著差异;透明细胞肾细胞癌的ADC值及增强期对比增强率、对比增强指数显著高于非透明细胞肾细胞癌;乏脂性血管平滑肌脂肪瘤可借 wash-out 现象与其他肾脏肿块鉴别。联合应用ADC、信号强度、对比增强率与对比增强指数可能有助于区分肾细胞癌亚型、嗜酸细胞瘤及乏脂性血管平滑肌脂肪瘤。

要点

  • 良恶性实性肾脏肿块间ADC1、ADC2及信号强度无显著差异(p值分别为0.721、0.255、0.872)。
  • 透明细胞肾细胞癌的ADC1与ADC2值显著高于非透明细胞肾细胞癌(p=0.005与p=0.002)。
  • 乏脂性血管平滑肌脂肪瘤与其他肾脏肿块的鉴别可依据 wash-out 现象。

诊断标准与关键数值

  • 良性与恶性肾脏肿块间ADC1、ADC2值及信号强度均无显著差异(p=0.721、p=0.255、p=0.872)。
  • 透明细胞肾细胞癌的平均ADC1与ADC2值显著高于非透明细胞肾细胞癌(p=0.005与p=0.002)。
  • 透明细胞肾细胞癌在肾实质期的平均对比增强率显著高于非透明细胞肾细胞癌(p=0.003)。
  • 透明细胞肾细胞癌在皮髓质期与肾实质期的平均对比增强指数均显著高于非透明细胞肾细胞癌(p=0.027与p=0.008)。
  • 乏脂性血管平滑肌脂肪瘤与其他肾脏肿块的鉴别依据 wash-out 现象。

临床应用与阅片要点

  • 阅片时可测量肾脏肿块的ADC1与ADC2值,透明细胞肾细胞癌的ADC值显著高于非透明细胞肾细胞癌。
  • 在皮髓质期与肾实质期计算对比增强率与对比增强指数,透明细胞肾细胞癌的对比增强率(肾实质期)与对比增强指数(两期)显著高于非透明细胞肾细胞癌。
  • 注意 wash-out 现象有助于将乏脂性血管平滑肌脂肪瘤与其他肾脏肿块区分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the value of diffusion-weighted magnetic resonance imaging (DW-MRI) and contrast-enhanced MRI (CE-MRI) for differentiation between benign and malignant solid renal masses, renal cell carcinoma (RCC) subtypes, oncocytomas, and lipid-poor angiomyolipomas (LP-AML).

METHODS: Minimum or lowest 'apparent diffusion coefficient' (ADC1) and representative ADC values (ADC2) of 112 renal masses (n: 46 benign renal mass, n: 66 malignant renal mass) were measured on DW-MRI images (b 50, 400, 800 s/mm2). Signal intensity (SI) measurements were performed in normal renal parenchyma and most avid enhanced area of the renal masses at precontrast, corticomedullary, and nephrographic phases on CE-MRI. Contrast enhancement rate (CER) and contrast enhancement index (CEI) values of renal masses were compared between benign-malignant renal masses and RCC subtypes, oncocytomas, and LP-AMLs.

RESULTS: There was no significant difference between ADC1, ADC2 values, and SI of benign and malignant renal masses (p = 0.721, p = 0.255, p = 0.872). Mean ADC1 and ADC2 values of clear cell RCCs were significantly higher than nonclear cell RCCs (p = 0.005 p = 0.002). Mean CER value of clear cell RCCs was significantly higher than nonclear cell RCCs in nephrographic phase (p = 0.003). Mean CEI values of clear cell RCCs were significantly higher than nonclear cell RCCs in the corticomedullary and nephrographic phase (p = 0.027 vs. 0.008). LP-AMLs were differentiated from other renal masses with wash-out phenomenon.

CONCLUSION: Combined usage of ADC, SI, CER, and CEI values may be useful for discrimination between RCC subtypes, oncocytomas, and lipid-poor AMLs.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Serter A, Onur MR, Coban G, et al. The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes. Abdom Radiol (NY). 2020. PMID: 32930832. doi:10.1007/s00261-020-02742-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。